Optilume balloon dilation for radiation induced posterior urethral stenosis: a multi-institutional experience

Abstract Introduction Radiation induced urethral stenosis disease represents a complex subset of patients with higher rates of recurrence after treatment. Optilume®, a Paclitaxel drug-coated balloon, has been utilized in anterior urethral strictures with promising results. Although urethroplasty is...

Full description

Saved in:
Bibliographic Details
Main Authors: Brian Ceballos, Eshan G. Joshi, Kayla Graham, Luke Shumaker, Katherine Englander, Victoria Stowasser, J. Patrick Selph, Lucas Wiegand, Kevin Heinsimer, Maxim McKibben, Maia VanDyke, Steven Hudak, Allen Morey, Adam Baumgarten
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Urology
Subjects:
Online Access:https://doi.org/10.1186/s12894-025-01829-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332271202435072
author Brian Ceballos
Eshan G. Joshi
Kayla Graham
Luke Shumaker
Katherine Englander
Victoria Stowasser
J. Patrick Selph
Lucas Wiegand
Kevin Heinsimer
Maxim McKibben
Maia VanDyke
Steven Hudak
Allen Morey
Adam Baumgarten
author_facet Brian Ceballos
Eshan G. Joshi
Kayla Graham
Luke Shumaker
Katherine Englander
Victoria Stowasser
J. Patrick Selph
Lucas Wiegand
Kevin Heinsimer
Maxim McKibben
Maia VanDyke
Steven Hudak
Allen Morey
Adam Baumgarten
author_sort Brian Ceballos
collection DOAJ
description Abstract Introduction Radiation induced urethral stenosis disease represents a complex subset of patients with higher rates of recurrence after treatment. Optilume®, a Paclitaxel drug-coated balloon, has been utilized in anterior urethral strictures with promising results. Although urethroplasty is traditionally regarded as the gold standard for treating radiation-induced posterior urethral stenosis, it can be an invasive and challenging procedure with potential side effects. We aim to evaluate the efficacy of the Optilume® drug-coated balloon as a minimally invasive treatment option for radiation-induced posterior urethral stenosis. Methods A retrospective, multi-institutional review was conducted on male patients who underwent Optilume® drug-coated balloon dilation from January 1, 2022, to November 1, 2023. The study involved five surgeons across four institutions. Patients were investigated based on their history of radiation-induced posterior urethral stenosis, and comparisons were made regarding demographics, characteristics of urethral stenosis, and outcomes, including surgical success and complications. Results Among the 56 patients with radiation-induced posterior urethral stenosis evaluated across all four institutions, 37 men had at least 90-day follow-up data. Of these 37 patients, 30 (81.1%) were deemed successful, defined as being free from repeat intervention. Although 6 patients (10.7%) experienced complications, none were greater than Clavien IIIb, with the most common complication being acute urinary retention. Conclusion Although radiation-induced urethral stenosis is typically associated with high rates of recurrence following conservative treatment, Optilume® drug-coated balloon represents an alternative endoscopic treatment option with encouraging short-term results.
format Article
id doaj-art-cfbdaa03e1eb4a6cb19497ee91ea342b
institution Kabale University
issn 1471-2490
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Urology
spelling doaj-art-cfbdaa03e1eb4a6cb19497ee91ea342b2025-08-20T03:46:15ZengBMCBMC Urology1471-24902025-07-012511410.1186/s12894-025-01829-0Optilume balloon dilation for radiation induced posterior urethral stenosis: a multi-institutional experienceBrian Ceballos0Eshan G. Joshi1Kayla Graham2Luke Shumaker3Katherine Englander4Victoria Stowasser5J. Patrick Selph6Lucas Wiegand7Kevin Heinsimer8Maxim McKibben9Maia VanDyke10Steven Hudak11Allen Morey12Adam Baumgarten13Department of Urology, University of Alabama at BirminghamDepartment of Urology, University of Texas Southwestern Medical CenterDepartment of Urology, Atrium HealthDepartment of Urology, University of Alabama at BirminghamDepartment of Urology, University of South FloridaDepartment of Urology, University of Alabama at BirminghamUrology Associates of NashvilleDepartment of Urology, University of South FloridaDepartment of Urology, University of South FloridaDepartment of Urology, Atrium HealthDepartment of Urology, University of Texas Southwestern Medical CenterDepartment of Urology, University of Texas Southwestern Medical CenterUrology Clinics of North TexasDepartment of Urology, University of Alabama at BirminghamAbstract Introduction Radiation induced urethral stenosis disease represents a complex subset of patients with higher rates of recurrence after treatment. Optilume®, a Paclitaxel drug-coated balloon, has been utilized in anterior urethral strictures with promising results. Although urethroplasty is traditionally regarded as the gold standard for treating radiation-induced posterior urethral stenosis, it can be an invasive and challenging procedure with potential side effects. We aim to evaluate the efficacy of the Optilume® drug-coated balloon as a minimally invasive treatment option for radiation-induced posterior urethral stenosis. Methods A retrospective, multi-institutional review was conducted on male patients who underwent Optilume® drug-coated balloon dilation from January 1, 2022, to November 1, 2023. The study involved five surgeons across four institutions. Patients were investigated based on their history of radiation-induced posterior urethral stenosis, and comparisons were made regarding demographics, characteristics of urethral stenosis, and outcomes, including surgical success and complications. Results Among the 56 patients with radiation-induced posterior urethral stenosis evaluated across all four institutions, 37 men had at least 90-day follow-up data. Of these 37 patients, 30 (81.1%) were deemed successful, defined as being free from repeat intervention. Although 6 patients (10.7%) experienced complications, none were greater than Clavien IIIb, with the most common complication being acute urinary retention. Conclusion Although radiation-induced urethral stenosis is typically associated with high rates of recurrence following conservative treatment, Optilume® drug-coated balloon represents an alternative endoscopic treatment option with encouraging short-term results.https://doi.org/10.1186/s12894-025-01829-0Urethral strictureRadiationOptilumeBalloon dilation
spellingShingle Brian Ceballos
Eshan G. Joshi
Kayla Graham
Luke Shumaker
Katherine Englander
Victoria Stowasser
J. Patrick Selph
Lucas Wiegand
Kevin Heinsimer
Maxim McKibben
Maia VanDyke
Steven Hudak
Allen Morey
Adam Baumgarten
Optilume balloon dilation for radiation induced posterior urethral stenosis: a multi-institutional experience
BMC Urology
Urethral stricture
Radiation
Optilume
Balloon dilation
title Optilume balloon dilation for radiation induced posterior urethral stenosis: a multi-institutional experience
title_full Optilume balloon dilation for radiation induced posterior urethral stenosis: a multi-institutional experience
title_fullStr Optilume balloon dilation for radiation induced posterior urethral stenosis: a multi-institutional experience
title_full_unstemmed Optilume balloon dilation for radiation induced posterior urethral stenosis: a multi-institutional experience
title_short Optilume balloon dilation for radiation induced posterior urethral stenosis: a multi-institutional experience
title_sort optilume balloon dilation for radiation induced posterior urethral stenosis a multi institutional experience
topic Urethral stricture
Radiation
Optilume
Balloon dilation
url https://doi.org/10.1186/s12894-025-01829-0
work_keys_str_mv AT brianceballos optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT eshangjoshi optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT kaylagraham optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT lukeshumaker optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT katherineenglander optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT victoriastowasser optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT jpatrickselph optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT lucaswiegand optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT kevinheinsimer optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT maximmckibben optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT maiavandyke optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT stevenhudak optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT allenmorey optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience
AT adambaumgarten optilumeballoondilationforradiationinducedposteriorurethralstenosisamultiinstitutionalexperience